Prescriber's Corner

Cabozantinib for the Treatment of Metastatic Medullary Thyroid Carcinoma

Nancy M. Nix, PharmD, BCPS, BCOP, and Kirk Braun*

From St. Joseph’s/Candler Health System, South Carolina Cancer Specialists, Hilton Head, South Carolina; University of Georgia College of Pharmacy, Athens, Georgia

Authors' disclosures of potential conflicts of interest are found at the end of this article.

Correspondence to: Nancy M. Nix, PharmD, BCPS, BCOP, South Carolina Cancer Specialists, PO Box 21824, Hilton Head, SC 29925. E-mail: nixna@sjchs.org


J Adv Pract Oncol 2014;5:47-50# | DOI: 10.6004/jadpro.2014.5.1.10 | © 2014 Harborside Press®


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me